drugset / Trial / NCT01437371
Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?
Phase 3
Completed
35 enrolled
University Hospital, Clermont-Ferrand
LivaNova · collabServier · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if there is an interest to optimize HF (heart failure) management in patients over 80 years old. The primary objective is to assess the effect of HF (heart failure) optimized management (guidelines of the European society of Cardiology (ESC) on Quality of Life (QOL) in aged over 80 year's old at 6 months.
Timeline
- Start
- 2011-08
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Captopril | Small molecule | — | — |
| Background | Enalapril | Other / unclassified | — | — |
| Background | LISINOPRIL ANHYDROUS | Small molecule | — | — |
| Background | Ramipril | Small molecule | — | — |
| Background | trandolapril | Small molecule | — | — |